Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study
Conte, P., Frassoldati, A., Bisagni, G., Brandes, A.A., Donadio, M., Garrone, O., Piacentini, F., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Molino, A., Musolino, A., Ferro, A., Maltoni, R., Danese, S., Zamagni, C., Rimanti, A., Cagossi, K., Russo, A., Pronzato, P., Giovanardi, F., Moretti, G., Lombardo, L., Schirone, A., Beano, A., Amaducci, L., Bajardi, E.A., Vicini, R., Balduzzi, S., D’Amico, R., Guarneri, V.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer
Dieci, M.V., Conte, P., Bisagni, G., Brandes, A.A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S., D’Amico, R., Guarneri, V.
Published in Annals of oncology (01.03.2019)
Published in Annals of oncology (01.03.2019)
Get full text
Journal Article
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer
Musolino, A, Naldi, N, Dieci, M V, Zanoni, D, Rimanti, A, Boggiani, D, Sgargi, P, Generali, D G, Piacentini, F, Ambroggi, M, Cagossi, K, Gianni, L, Sarti, S, Bisagni, G, Ardizzoni, A, Conte, P F, Guarneri, V
Published in The pharmacogenomics journal (01.10.2016)
Published in The pharmacogenomics journal (01.10.2016)
Get full text
Journal Article
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio
Conte, P.F., Guarneri, V., Bisagni, G., Piacentini, F., Brandes, A.A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Frassoldati, A., Musolino, A., Garrone, O., Taverniti, C., Rimanti, A., Sarti, S., Rubino, D., Bologna, A., Vicini, R., Balduzzi, S., D'Amico, R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial
Dieci, M.V., Conte, P.F., Bisagni, G., Brandes, A.A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Omarini, C., Maiorana, A., Orvieto, E., Sanders, M., D'Amico, R., Guarneri, V.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study
Musolino, A., Falcini, F., Sikokis, A., Boggiani, D., Rimanti, A., Pellegrino, B., Silini, E.M., Campanini, N., Barbieri, E., Zamagni, C., Degli Esposti, R., Cortesi, L., Bisagni, G., Cavanna, L., Frassoldati, A., Sgargi, P., Michiara, M.
Published in European journal of cancer (1990) (01.01.2018)
Published in European journal of cancer (1990) (01.01.2018)
Get full text
Journal Article
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial
Poggio, F., Blondeaux, E., Tagliamento, M., Perachino, M., Nardin, S., Conte, B., Giuliano, M., Arpino, G., De Laurentiis, M., Gravina, A., Bisagni, G., Rimanti, A., Turletti, A., Nisticò, C., Magnolfi, E., Gasparro, S., Fabi, A., Garrone, O., Alicicco, M.G., Urracci, Y., Poletti, P., Correale, P., Molinelli, C., Fozza, A., Puglisi, F., Colantuoni, G., Fregatti, P., Boni, L., Lambertini, M., Del Mastro, L.
Published in ESMO open (01.08.2024)
Published in ESMO open (01.08.2024)
Get full text
Journal Article
239MO TILs and overall survival (OS) in HER2+ early breast cancer (eBC): 10-year (yr) updated analysis of the ShortHER trial
Dieci, M.V., Bisagni, G., Bartolini, S., Schirone, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., E. bertone, Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S., D'Amico, R., Guarneri, V.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella (GIM) and Mammella Intergruppo trials (MIG)
Blondeaux, E., Xie, W., Carmisciano, L., Mura, S., Sanna, V., De Laurentiis, M., Caputo, R., Turletti, A., Durando, A., De Angelis, C., Bisagni, G., Gasparini, E., Rimanti, A., Puglisi, F., Landucci, E., Fabi, A., Boni, L., Lambertini, M., Del Mastro, L., Regan, M.M.
Published in European journal of cancer (1990) (01.03.2024)
Published in European journal of cancer (1990) (01.03.2024)
Get full text
Journal Article
19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study
Guarneri, V., Dieci, M.V., Bisagni, G., Brandes, A.A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Nanni, O., Piacentini, F., Orvieto, E., Curtarello, M., Chic, N., D'Amico, R., Prat, A., Conte, P.F.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article
191PD_PR9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio
Conte, P F, Guarneri, V, Bisagni, G, Piacentini, F, Brandes, A A, Cavanna, L, Giotta, F, Aieta, M, Gebbia, V, Frassoldati, A, Musolino, A, Garrone, O, Taverniti, C, Rimanti, A, Sarti, S, Rubino, D, Bologna, A, Vicini, R, Balduzzi, S, D'Amico, R
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
186OTumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial
Dieci, M V, Conte, P F, Bisagni, G, Brandes, A A, Frassoldati, A, Cavanna, L, Musolino, A, Giotta, F, Rimanti, A, Garrone, O, Bertone, E, Cagossi, K, Sarti, S, Ferro, A, Omarini, C, Maiorana, A, Orvieto, E, Sanders, M, D'Amico, R, Guarneri, V
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Abstract P1-07-23: Prognostic impact of HER2 overexpression/amplification in women with pT1a N0 M0 breast cancer with known screening status: Results from a multicenter population-based cancer registry study
Musolino, A, Michiara, M, Boggiani, D, Sikokis, A, Rimanti, A, Pellegrino, B, Silini, EM, Campanini, N, Barbieri, E, Sgargi, P, Falcini, F, Pinto, C
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
palliative care Evaluation of effects of early palliative care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial
Franciosi, V., Caruso, G., Maglietta, G., De Esposti, Cgli, Cavanna, L., Bertè, R., Bacchini, G., Bocchi, L., Piva, E., Monfredo, M., Scafuri, V., Di Cesare, P., Melotti, B., Sequino, M., Rimanti, A., Binovi, C., Ghisoni, F., Caminiti, C.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study
Musolino, A., Sikokis, A., Boggiani, D., Rimanti, A., Pellegrino, B., Silini, E.M., Campanini, N., Barbieri, E., Cortesi, L., Panebianco, M., Porzio, R., Frassoldati, A., Sgargi, P., Falcini, F., Michiara, M.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Effects of simultaneous care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial
Franciosi, V., Caruso, G., Degli Esposti, C., Cavanna, L., Berte', R., Bacchini, G.P., Bocchi, L., Monfredo, M., Di Cesare, P., Melotti, B., Piva, E., Scafuri, V., Maglietta, G., Sequino, M., RIMANTI, A., Binovi, C., GHISONI, F., Caminiti, C.
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article
Prognostic Impact of Interval Breast Cancer Detection in Women with pT1aN0M0 Breast Cancer with HER2-positive Status: Results from a Multicenter Population-based Cancer Registry Study
Boggiani, D., Sikokis, A., Rimanti, A., Pellegrino, B., Silini, E.M., Campanini, N., Barbieri, E., Cortesi, L., Panebianco, M., Porzio, R., Frassoldati, A., Sgargi, P., Falcini, F., Michiara, M., Musolino, A.
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article
101P Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: An individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies
Lambertini, M., Blondeaux, E., Bisagni, G., Mura, S., de Placido, S., De Laurentiis, M., Fabi, A., Rimanti, A., Michelotti, A., Mansutti, M., Russo, A., Montemurro, F., Frassoldati, A., Durando, A., Gori, S., Turletti, A., Tamberi, S., Urracci, Y., de Azambuja, E., Del Mastro, L.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
Immunohistochemistry (IHC) analysis with 3 different antibodies (Abs) and thymidylate synthase (TS) evaluation of FISH-positive ALK-rearranged (ALK+) lung adenocarcinomas (ADK)
Bironzo, P., Monica, V., Graziano, P., Muscarella, L.A., Righi, L., Busso, S., Di Micco, C., Rimanti, A., Fulvi, A., Consito, L., Bertolini, F., Lombardi, A., Vincenzi, G., Rossi, G., Novello, S.
Published in Annals of oncology (01.10.2015)
Published in Annals of oncology (01.10.2015)
Get full text
Journal Article